BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Jan 23, 15:49Prev. Close
91.38
Open Price
89.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Par Drugs & Chemicals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 5.99 | 3.28 | 2.55 | 3.18 | 1.31 | |
| Net CashFlow From Operating Activities | 7.69 | 7.58 | 4.32 | 9.17 | 6.47 | |
| Net Cash Used In Investing Activities | -1.46 | -0.25 | -0.60 | -1.70 | -0.11 | |
| Net Cash Used From Financing Activities | 1.11 | -7.36 | -3.67 | -8.38 | -5.46 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 7.35 | -0.03 | 0.05 | -0.91 | 0.90 | |
| Cash And Cash Equivalents Begin of Year | 0.03 | 0.06 | 0.02 | 0.93 | 0.03 | |
| Cash And Cash Equivalents End Of Year | 7.38 | 0.03 | 0.06 | 0.02 | 0.93 |
27.11.2025
Par Drugs Standalone September 2025 Net Sales at Rs 28.66 crore, down 17.31% Y-o-Y
22.08.2025
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y
12.05.2025
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y
23.10.2024
Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
15.03.2018
24.04.2017
24.04.2017
20.04.2017